CELLforCURE, THE INDUSTRIAL PLAYER bringing YOUR CELL THERAPY PRODUCT UP TO MARKET.

Cell therapy, at the cellular of tomorrow's personalized medicine is expected to provide new ways of preventing or treating a wide range of diseases.

According to its customers and partners needs, in compliance with international regulatory requirements, CELLforCURE enables you :

- to industrialize and automate your autologous and/or allogeneic processes

- to produce your cell therapy products in industrial GMP facilities, from clinical to commercial scale

- to provide pharmaceutical and regulatory services, as well as pharmaceutical distribution of your cell therapy products.

News & Events
  • Press Release - News

    PRESS RELEASE
    Cellectis Enters into New Agreement with CELLforCURE
    for the cGMP Manufacturing of UCART123 for Hematological Malignancies (see press release here attached - indicated below by "show")
    _____________________________________________

    CELLforCURE will have a booth at Cell and Gene Therapies B4B-Connection at Evry on February 3-4th, 2016.

    __________________________________________________









































    Show
Our Partners
  • EFS
  • Celogos
  • Clean Cells
  • Hôpitaux de Lyon
  • Hôpitaux de Bordeaux
  • CHRU de Lille
  • Hôpitaux de Toulouse
  • UTCG